1 |
Huber GF, Fritzsche FR, Züllig L, et al. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. Int J Cancer 2011;129:1404-9.
DOI
|
2 |
Amioka T, Kitadai Y, Tanaka S, et al. Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer 2002;38:1413-9.
DOI
ScienceOn
|
3 |
Hadler-Olsen E, Wetting HL, Rikardsen O, et al. Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts. Virchows Arch 2010;457:677-92.
DOI
|
4 |
Funayama A, Cheng J, Maruyama S, et al. Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas. Pathobiology 2011;78:171-80.
DOI
|
5 |
Lee SW, Park YW. Expression of endoglin and podoplanin in early and advanced oral squamous cell carcinoma. J Korean Assoc Oral Maxillofac Surg 2012;38:145-51.
DOI
ScienceOn
|
6 |
Sedivy R, Beck-Mannagetta J, Haverkampf C, Battistutti W, Honigschnabl S. Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer. J Oral Pathol Med 2003;32:455-60.
DOI
ScienceOn
|
7 |
Kähäri VM, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 1999;31:34-45.
DOI
ScienceOn
|
8 |
Tsirlis TD, Papastratis G, Masselou K, et al. Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J Gastroenterol 2008;14:2691-701.
DOI
|
9 |
Miyahara M, Tanuma J, Sugihara K, Semba I. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer 2007;110:1287-94.
DOI
ScienceOn
|
10 |
Park YW, Kim SG, Kim SH, Kim HS, Kim MK. Gene expression for lymphangiogenic factors in oral mucosal squamous cell carcinoma. J Korean Assoc Maxillofac Plast Reconstr Surg 2009;31:453-60.
|
11 |
Zhang Z, Pan J, Li L, Wang Z, Xiao W, Li N. Survey of risk factors contributed to lymphatic metastasis in patients with oral tongue cancer by immunohistochemistry. J Oral Pathol Med 2011;40:127-34.
DOI
|
12 |
Park YW, Kwon KJ, Lee JW. Immunohistochemical study on expression of lymphangiogenic factors in oral cancer. J Korean Assoc Maxillofac Plast Reconstr Surg 2010;32:1-8.
|
13 |
Tang RF, Itakura J, Aikawa T, et al. Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer. Pancreas 2001;22:285-92.
DOI
ScienceOn
|
14 |
Warburton G, Nikitakis NG, Roberson P, et al. Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma. J Oral Maxillofac Surg 2007;65:475-84.
DOI
ScienceOn
|
15 |
Matsuura M, Onimaru M, Yonemitsu Y, et al. Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells. Am J Pathol 2009;175:1709-21.
DOI
|
16 |
Kitadai Y, Amioka T, Haruma K, et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer 2001;93:662-6.
DOI
ScienceOn
|
17 |
Wicki A, Christofori G. The potential role of podoplanin in tumour invasion. Br J Cancer 2007;96:1-5.
DOI
|
18 |
Achen MG, Stacker SA. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Int J Cancer 2006;119:1755-60.
DOI
ScienceOn
|
19 |
Wigle JT, Harvey N, Detmar M, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002;21:1505-13.
DOI
ScienceOn
|
20 |
Jackson DG, Prevo R, Clasper S, Banerji S. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 2001;22:317-21.
DOI
ScienceOn
|
21 |
Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290-8.
|
22 |
O-charoenrat P, Rhys-Evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 2001;92:556-68.
DOI
|
23 |
Witte D, Thomas A, Ali N, Carlson N, Younes M. Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma. Anticancer Res 2002;22:1463-6.
|
24 |
Brychtova S, Bezdekova M, Brychta T, Tichy M. The role of vascular endothelial growth factors and their receptors in malignant melanomas. Neoplasma 2008;55:273-9.
|
25 |
Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 1995;92:3566-70.
DOI
ScienceOn
|
26 |
Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 1990;66:109-13.
DOI
|
27 |
Fronie A, Bunget A, Afrem E, et al. Squamous cell carcinoma of the oral cavity: clinical and pathological aspects. Rom J Morphol Embryol 2013;54:343-8.
|
28 |
Pepper MS. Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res 2001;7:462-8.
|
29 |
Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260-70.
DOI
ScienceOn
|